Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
Submitted by
admin
on November 19, 2021 - 10:52am
Source:
Motley Fool
News Tags:
Merck
Pfizer
antivirals
COVID-19
molnupiravir
Paxlovid
Headline:
Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
snippet:
When Merck released findings from its COVID pill, its stock soared more than 10%.
But with Pfizer's pill showing superior efficacy, Merck shares have quickly reversed course.
The market could be large enough to support both pills -- but that relies on a lot of assumptions.
Do Not Allow Advertisers to Use My Personal information